Altacor, Nicox deal

NicOx will acquire an 11.8% stake in ophthalmic company Altacor for £2 million ($3.2 million) in cash. NicOx also received an exclusive option to acquire the remaining Altacor shares for an additional £9 million ($14.2 million) in cash and/or stock. The option expires May 31. If the option is exercised, Altacor shareholders would be eligible to receive up to an additional £8.5 million ($13.5 million) in milestones, including payments related to a potential NDA submission in the U.S. for Altacor's ALT-005. The ophthalmic surgical antiseptic solution is in a Phase III trial. ...